Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03726320 · ClinicalTrials.gov registry record · NA

Trial of Community Health Worker-led Decision Coaching

A NA study of Prostate Cancer, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
162
Enrollment target
1
Study location

NCT03726320 is a NA study of Prostate Cancer that has completed, run by NYU Langone Health. The registered enrollment target is 162 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03726320, a NA study of Prostate Cancer, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
162 participants
Enrollment target
1
Study location

Study Summary

Black men are disproportionately affected by prostate cancer, the most common non-cutaneous malignancy among men in the U.S. This randomized trial will evaluate the efficacy of a Community Health Worker-led decision coaching program to facilitate Shared Decision Making (SDM) and Prostate Specific Antigen (PSA) screening among Black men with regards to decision quality, the decision making process, patient-provider communication and PSA utilization for Black men in the primary care setting.

Conditions Studied

Interventions

  • BEHAVIORAL Education Counseling Session for PSA Screening
  • BEHAVIORAL General Health Counseling Coaching

Study Locations (1)

New York

  • New York University School of Medicine - New York

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2019-10-15
Est. Completion 2023-09-20
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT03726320

The ClinicalTrials.gov registry entry for NCT03726320 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (73% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Education Counseling Session for PSA Screening is the first listed.

NCT03726320 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03726320 about?

NCT03726320 is a clinical study titled "Trial of Community Health Worker-led Decision Coaching". Black men are disproportionately affected by prostate cancer, the most common non-cutaneous malignancy among men in the U.S. This randomized trial will evaluate the efficacy of a Community Health Worker-led decision coaching program to facilitate Shared Decision Making (SDM) and Prostate Specific An...

What is the current status of trial NCT03726320?

This trial is currently completed. It is a NA study. The enrollment target is 162 participants. The study started on 2019-10-15. Estimated completion is 2023-09-20.

What conditions does trial NCT03726320 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT03726320?

The interventions under investigation include: Education Counseling Session for PSA Screening (BEHAVIORAL), General Health Counseling Coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT03726320?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03726320 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.